tiprankstipranks
Xenetic Biosciences, Inc. (XBIO)
:XBIO
US Market
Holding XBIO?
Track your performance easily

Xenetic Biosciences (XBIO) Financial Statements

295 Followers

Xenetic Biosciences Financial Overview

Xenetic Biosciences's market cap is currently ―. The company's EPS TTM is $-2.647; its P/E ratio is ―; Xenetic Biosciences is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 614.24K$ 510.82K$ 611.17K$ 651.00K$ 605.84K
Gross Profit$ 614.24K$ 510.82K$ 611.17K$ 651.00K$ 605.84K
EBIT$ -497.97K$ -1.20M$ -1.15M$ -1.20M$ -856.55K
EBITDA$ -497.97K$ -1.20M$ -1.15M$ -1.20M$ -856.55K
Net Income Common Stockholders$ -436.67K$ -1.20M$ -1.06M$ -1.05M$ -856.55K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.84M$ 7.82M$ 9.78M$ 10.73M$ 11.99M
Total Assets$ 8.05M$ 9.39M$ 11.96M$ 12.75M$ 13.72M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 1.01M$ 716.49K$ 1.07M$ 871.32K$ 856.37K
Stockholders Equity$ 7.04M$ 8.68M$ 10.89M$ 11.88M$ 12.86M
Cash Flow-
Free Cash Flow$ -459.04K$ -1.16M$ -949.63K$ -1.27M$ -1.10M
Operating Cash Flow$ -459.04K$ -1.16M$ -949.63K$ -1.27M$ -1.10M
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Xenetic Biosciences Earnings and Revenue History

Xenetic Biosciences Debt to Assets

Xenetic Biosciences Cash Flow

Xenetic Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis